Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate

被引:0
|
作者
Fassinger, N [1 ]
Dabbagh, S [1 ]
Mukhopadhyay, S [1 ]
Lee, DY [1 ]
机构
[1] Wayne State Univ, Childrens Hosp Michigan, Dept Pediat, Detroit, MI 48201 USA
来源
ADVANCES IN PERITONEAL DIALYSIS/1998, VOL 14 | 1998年 / 14卷
关键词
hyperkalemia; neonates; renal insufficiency; infant formula; potassium exchange resin;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Options for the management of infants with hyperkalemia secondary to renal insufficiency are limited for infants not maintained on dialysis. Precipitation of potassium (K+) from infant formula with sodium polystyrene sulfonate (KX) prior to feeding has been reported However; its effect on calcium (Ca2+) and sodium (naf) has not been quantitatively defined. The purpose of this study was to examine the effects of two K+ exchange resins: KX and calcium polystyrene sulfonate (RC) on Na+, K+, and Ca2+. Infant formula powder (Similac PM60/40, Ross Laboratories, Columbus, OH, USA) was prepared with deionized water (DW) and KX or RC (I g/mEq of K+) was added. The formula was decanted after 50 minutes and Na+, K+, and Ca2+ were assayed in the supernatant. Na+ and K+ were also assayed in ready-to-feed PM 60/40 (RTF). KX decreased the K+ concentration by 4.5 fold (P < 0.001) and increased the Na+ content by 3.8 fold (P < 0.001). In RC there was a 1.6-fold increase in Ca2+ content (P < 0.001), and a 13% decrease in K+ concentrations (P < 0.05). Preparation of the formula with DW reduced the K+ concentration by 30% compared to ready-to-feed formula (P < 0.001). We conclude that, although KX significantly reduces the K+ content of formulas, DW may be a more practical and convenient method of preparing formula for the hyperkalemic infant.
引用
收藏
页码:274 / 277
页数:4
相关论文
共 50 条
  • [1] Pretreatment of Infant Formula with Sodium Polystyrene Sulfonate Focus on Optimal Amount and Contact Time
    Cameron, Jean-Christy F.
    Kennedy, Dana
    Feber, Janusz
    Wong, Elaine
    Geier, Pavel
    Vaillancourt, Regis
    PEDIATRIC DRUGS, 2013, 15 (01) : 43 - 48
  • [2] Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate
    Lee, Ji
    Moffett, Brady S.
    PEDIATRIC NEPHROLOGY, 2016, 31 (11) : 2113 - 2117
  • [3] Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate
    Ji Lee
    Brady S. Moffett
    Pediatric Nephrology, 2016, 31 : 2113 - 2117
  • [4] Sodium polystyrene sulfonate damage
    Fogt, F
    Vortmeyer, AO
    Senderowicz, AM
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (03) : 379 - 380
  • [5] Sodium Polystyrene Sulfonate for Hyperkalemia
    Parks, Monica
    Grady, Deborah
    JAMA INTERNAL MEDICINE, 2019, 179 (08) : 1023 - 1024
  • [6] CLEANSING ENEMAS AFTER SODIUM POLYSTYRENE SULFONATE ENEMAS
    SHEPARD, KV
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) : 711 - 711
  • [7] An Alternative to Sodium Polystyrene Sulfonate and Patiromer for the Treatment of Hyperkalemia
    Sabir, Ian
    JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1600 - 1600
  • [8] Sodium polystyrene sulfonate - is it truly effective treatment for hyperkalemia?
    Einbinder, Yael
    Korzets, Ze'ev
    Goodman, Debbie J.
    Benchetrit, Sydney
    CLINICAL NEPHROLOGY, 2015, 83 (01) : 71 - 72
  • [9] Rectally administered sodium polystyrene sulfonate
    Gales, MA
    Gale, BJ
    Dyer, ME
    Orr, SR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (24) : 2813 - 2815
  • [10] Sodium polystyrene sulfonate (Kayexalate) aspiration
    Luis F Gonzalez-Cuyar
    Nathaniel B Cresswell
    Allen P Burke
    Diagnostic Pathology, 3